Fig. 3

Artificial intelligence-guided tumor drug clinical practice. a AI models predict patient responses to specific drugs and identify and differentiate individuals with distinct drug-resistant phenotypes. b AI models screen predictive and prognostic biomarkers associated with drug resistance